EUVIMEDEUVIMED entdecken
Open Access

Thirteen-Year Trends and Advancements of Endovascular Therapy for Dural Arteriovenous Fistulas in Japan: Insights from a Nationwide Study of 6470 Procedures

Satoshi Murai iD, Tomohito Hishikawa iD, Masafumi Hiramatsu iD, Jun Haruma iD, Kenji Sugiu iD, Koji Iihara, Hirotoshi Imamura iD, Akira Ishii iD, Yuji Matsumaru iD, Chiaki Sakai iD, Tetsu Satow, Shinichi Yoshimura und 5 weitere

American Journal of Neuroradiology · 2025

DOI: 10.3174/ajnr.a8840 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2025. Verfasst von Satoshi Murai und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neurosurgery (S.M., T.H.), Kawasaki Medical School, Kurashiki, Okayama, Japan samurai3144@gmail.com. Hauptthemen laut MEDLINE: Central Nervous System Vascular Malformations, Endovascular Procedures, Embolization, Therapeutic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Japanese Society for Neuroendovascular Therapy, Kobayashi Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Endovascular therapy for dural arteriovenous fistulas (dAVFs) has evolved with advancements in imaging technology and devices. However, few large-scale, nationwide studies have been reported. This study aimed to investigate the trends and advancements in endovascular therapy for dAVFs during the past 13 years. MATERIALS AND METHODS: We identified patients from the Japanese Registry of Neuroendovascular Therapy (JR-NET) database treated for dAVFs between 2007 and 2019. We compared patient demographics, disease characteristics, treatment methods, and outcomes for JR-NET2 (2007-2009), JR-NET3 (2010-2014), and JR-NET4 (2015-2019). Prediction of complications was evaluated using multivariate logistic regression analysis. RESULTS: In total, we analyzed 6470 procedures. When we compared JR-NET2, 3, and 4, we found that the treatment for tentorial and anterior cranial fossa dAVFs has increased, and the use of precipitating liquid materials in transarterial embolization (TAE) increased to 31.7%. Complete obliteration in TAEs alone increased to 38.0%, with no significant changes in complication rates, morbidity, or mortality at 30 days. In JR-NET2 and 3, complications were significantly associated with the cavernous sinus, tentorium, anterior cranial fossa, and emergency treatment. In JR-NET4, aggressive symptoms and precipitating liquid embolic materials were significantly correlated with complications. Supervision by senior trainers significantly reduced complications. CONCLUSIONS: The use of precipitating liquid embolic materials has improved TAE outcomes. While their use has also emerged as a new risk factor for complications, supervision by senior trainers has been shown to mitigate these risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System Vascular MalformationsEndovascular ProceduresEmbolization, TherapeuticHumansMaleFemaleJapanMiddle AgedAgedRegistriesTreatment OutcomeAdultAged, 80 and over

Autor:innen und Institutionen

  • From the Department of Neurosurgery (S.M., T.H.), Kawasaki Medical School, Kurashiki, Okayama, Japan samurai3144@gmail.com.
  • From the Department of Neurosurgery (S.M., T.H.), Kawasaki Medical School, Kurashiki, Okayama, Japan.
  • Department of Neurological Surgery (M.H., J.H., K.S.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan.
  • Department of Neurosurgery (K.I., H.I.), National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Department of Neurosurgery (A.I.), Juntendo University Graduate School of Medicine, Bunkyo, Tokyo, Japan.
  • Department of Neurosurgery (Y.M.), Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

ORCID-Profile: Satoshi Murai, Tomohito Hishikawa, Masafumi Hiramatsu, Jun Haruma, Kenji Sugiu, Hirotoshi Imamura, Akira Ishii, Yuji Matsumaru, Chiaki Sakai, Nobuyuki Sakai

Förderung

  • The Japanese Society for Neuroendovascular Therapy
  • Kobayashi Foundation

Zitieren

APA

Murai, S., Hishikawa, T., Hiramatsu, M., Haruma, J., Sugiu, K., Iihara, K., Imamura, H., Ishii, A., Matsumaru, Y., Sakai, C., Satow, T., Yoshimura, S., Sakai, N., Japanese Registry of Neuroendovascular Therapy Investigators, JR-NET2 Study Group:, JR-NET3 Study Group:, & JR-NET4 Study Group: (2025). Thirteen-Year Trends and Advancements of Endovascular Therapy for Dural Arteriovenous Fistulas in Japan: Insights from a Nationwide Study of 6470 Procedures. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8840

Vancouver

Murai S, Hishikawa T, Hiramatsu M, Haruma J, Sugiu K, Iihara K, et al. Thirteen-Year Trends and Advancements of Endovascular Therapy for Dural Arteriovenous Fistulas in Japan: Insights from a Nationwide Study of 6470 Procedures. American Journal of Neuroradiology. 2025. doi:10.3174/ajnr.a8840

BibTeX
@article{Murai2025,
  author = {Murai, Satoshi and Hishikawa, Tomohito and Hiramatsu, Masafumi and Haruma, Jun and Sugiu, Kenji and Iihara, Koji and Imamura, Hirotoshi and Ishii, Akira and Matsumaru, Yuji and Sakai, Chiaki and Satow, Tetsu and Yoshimura, Shinichi and Sakai, Nobuyuki and Japanese Registry of Neuroendovascular Therapy Investigators, Japanese Registry of Neuroendovascular Therapy Investigators and JR-NET2 Study Group:, JR-NET2 Study Group: and JR-NET3 Study Group:, JR-NET3 Study Group: and JR-NET4 Study Group:, JR-NET4 Study Group:},
  title = {Thirteen-Year Trends and Advancements of Endovascular Therapy for Dural Arteriovenous Fistulas in Japan: Insights from a Nationwide Study of 6470 Procedures},
  journal = {American Journal of Neuroradiology},
  year = {2025},
  doi = {10.3174/ajnr.a8840}
}
Kostenlos starten →